Despite the fact that most chemotherapeutic agents do not enter the brain in significant amounts, recent research has shown they can produce a number of changes to the central nervous system, such as headaches, vision or hearing loss, and cognitive dysfunction, called “chemo fog.” “More researchers have begun to tease out the contribution of chemo” to cognitive decline, said Ellen Walker, professor of pharmaceutical sciences at Temple.